share_log
Moomoo 24/7 ·  Apr 11 17:16
Kyverna Therapeutics To Attend The 2024 AAN Annual Meeting With Data On KYV-101 In Treatment Of Patients With Neurological Autoimmune Diseases
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment